Viewing Study NCT02630693


Ignite Creation Date: 2025-12-25 @ 1:24 AM
Ignite Modification Date: 2025-12-31 @ 5:28 PM
Study NCT ID: NCT02630693
Status: COMPLETED
Last Update Posted: 2025-11-25
First Post: 2015-12-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer
Sponsor: Canadian Cancer Trials Group
Organization: